IRLAB Therapeutics AB (publ) Net Asset Quality Index
IRLAB Therapeutics AB (publ) net asset quality index. IRLAB Therapeutics AB (publ) (IRLAB-A) has a Net Asset Quality Index of 22.2% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr138.21 Million minus total liabilities of Skr107.49 Million yields net assets of Skr30.72 Million. A higher index indicates a stronger, lower-leverage balance sheet. See IRLAB-A net asset value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of IRLAB Therapeutics AB (publ) (2013–2025)
Net asset quality index of IRLAB Therapeutics AB (publ) from 2013 to 2025. This chart shows how IRLAB Therapeutics AB (publ)'s Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of December 2025, the index stands at 22.2%, representing net assets of Skr30.72 Million against total assets of Skr138.21 Million SEK. Check IRLAB Therapeutics AB (publ) strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
IRLAB Therapeutics AB (publ) Net Asset Quality Index by Year (2013–2025)
IRLAB Therapeutics AB (publ) net asset quality index by year from 2013 to 2025. The table below presents the year-by-year Net Asset Quality Index for IRLAB Therapeutics AB (publ) from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see IRLAB Therapeutics AB (publ) (IRLAB-A) market capitalisation.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 22.2% | Skr30.72 Million | Skr138.21 Million | Skr107.49 Million | ▼ -1.7 pp |
| 2024 | 24.0% | Skr32.63 Million | Skr136.21 Million | Skr103.58 Million | ▼ -41.4 pp |
| 2023 | 65.4% | Skr115.76 Million | Skr177.12 Million | Skr61.36 Million | ▼ -24.5 pp |
| 2022 | 89.9% | Skr290.83 Million | Skr323.56 Million | Skr32.72 Million | ▲ +5.3 pp |
| 2021 | 84.6% | Skr399.48 Million | Skr472.45 Million | Skr72.97 Million | ▼ -9.4 pp |
| 2020 | 94.0% | Skr347.88 Million | Skr370.07 Million | Skr22.19 Million | ▲ +6.6 pp |
| 2019 | 87.4% | Skr181.83 Million | Skr208.07 Million | Skr26.24 Million | ▼ -7.1 pp |
| 2018 | 94.5% | Skr212.48 Million | Skr224.94 Million | Skr12.46 Million | ▼ -0.6 pp |
| 2017 | 95.1% | Skr155.00 Million | Skr162.97 Million | Skr7.97 Million | ▲ +3.3 pp |
| 2016 | 91.8% | Skr103.89 Million | Skr113.11 Million | Skr9.22 Million | ▲ +0.8 pp |
| 2015 | 91.0% | Skr92.03 Million | Skr101.09 Million | Skr9.06 Million | ▲ +7.8 pp |
| 2014 | 83.2% | Skr88.57 Million | Skr106.43 Million | Skr17.86 Million | ▼ -16.7 pp |
| 2013 | 100.0% | Skr24.99 Million | Skr25.00 Million | Skr7.00K | — |